Efficacy of guselkumab in a subpopulation with pustulotic arthro‐osteitis through week 52: an exploratory analysis of a phase 3, randomized, double‐blind, placebo‐controlled study in Japanese patients with palmoplantar pustulosis

BACKGROUND: Previous studies of guselkumab have demonstrated clinical benefits in patients with plaque‐type psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and palmoplantar pustulosis (PPP). OBJECTIVE: The aim of this exploratory analysis of a double‐blind, multicenter, placebo‐co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, T., Fukuda, K., Morita, A., Kimura, T., Morishima, H., Goto, R., Zheng, R., Terui, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Psoriasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586986/
https://www.ncbi.nlm.nih.gov/pubmed/32173916
http://dx.doi.org/10.1111/jdv.16355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586986/
https://www.ncbi.nlm.nih.gov/pubmed/32173916
http://dx.doi.org/10.1111/jdv.16355

Ejemplares similares